Exchange: NSE·Updated 04:00 PM GMT+5:30

NOCIL.NSE News

News
all
press releases
Top stocks in news: RIL, AEL, Tata Motors, RVNL, Sun Pharma, LTTS, Zydus Life, GMDC, Nocil
… be amalgamated into AEL. Sun Pharmaceutical Industries: The pharma major said that the USFDA … chain in Gujarat. Zydus Lifesciences: The pharma company’s subsidiary Sentynl Therapeutics …
cityfalcon.com
More News
Brief India: PVR’s Two-Front War: Defending Premium SPH While Chasing Asset-Light Scale and more
In this briefing: PVR’s Two-Front War: Defending Premium SPH While Chasing Asset-Light Scale Gland Pharma Ltd - Poised for Stronger H2 Momentum; Rating Upgraded to BUY Westlife Foodworld Ltd - Resilience Amid Demand Softness; Maintain BUY Auto Monthly Sales Volume - October 2025 NOCIL Ltd - Pricing Pressure Continues; Global Uncertainties Adding to the Woes 1. PVR’s Two-Front War: Defending Premium SPH While Chasing Asset-Light Scale PVR Inox is piloting a full-service "dine-in" cinema concept in Bengaluru, while management confirms a major strategic shift towards an asset-light (FOCO) model for new screen expansion. The dine-in is a defensive move to protect premium Spend Per Head (SPH) against OTT, while the asset-light pivot is move to fix the balance sheet and scale in Tier-2/3. The company is re-engineering its business to be less dependent on its own capital, but its profitability remains entirely dependent on the one thing it cannot control: the content pipeline . 2. Gland Pharma Ltd - Poised for Stronger H2 Momentum; Rating Upgraded to BUY Stable Core and Cenexi Turnaround Drive Revenue Growth: Gland Pharma reported consolidated revenue of Rs 1,487 Cr in Q2FY26, marking a 5.8% YoY growth, in line with our estimates.
cityfalcon.com
Brief Equities Bottom-Up: Barry Callebaut (BARN SW) - Tuesday, Aug 5, 2025 and more
In this briefing: Barry Callebaut (BARN SW) - Tuesday, Aug 5, 2025 PICC P&C (2328 HK) - 3Q25 Review: Dual Strength in Underwriting and Investment Income NOCIL Ltd - Pricing Pressure Continues; Global Uncertainties Adding to the Woes Affle 3i Ltd. - Mixed Performance; Strong Momentum to Continue Ambuja Cements Ltd - Beat Estimates On Lower Cost; Retain BUY 1. Barry Callebaut (BARN SW) - Tuesday, Aug 5, 2025 Key points (machine generated) Barry Callebaut is the largest B2B chocolate maker, producing 20% of global industrial chocolate for major clients. High cocoa prices since early 2023 have led to decreased consumption and hedging losses, but the market is expected to stabilize by 2026. CEO Peter Feld is implementing cost cuts of CHF 250 million, and if cocoa prices normalize, the company's valuation could potentially double. This article is sourced from an online content aggregator through publicly available sources and is displayed below for general informational purposes only. This article was originally published 3 months ago on Value Investors Club. 2.
cityfalcon.com
Brief Growth Ideas: Barry Callebaut (BARN SW) - Tuesday, Aug 5, 2025 and more
In this briefing: Barry Callebaut (BARN SW) - Tuesday, Aug 5, 2025 PICC P&C (2328 HK) - 3Q25 Review: Dual Strength in Underwriting and Investment Income NOCIL Ltd - Pricing Pressure Continues; Global Uncertainties Adding to the Woes Affle 3i Ltd. - Mixed Performance; Strong Momentum to Continue Ambuja Cements Ltd - Beat Estimates On Lower Cost; Retain BUY 1. Barry Callebaut (BARN SW) - Tuesday, Aug 5, 2025 Key points (machine generated) Barry Callebaut is the largest B2B chocolate maker, producing 20% of global industrial chocolate for major clients. High cocoa prices since early 2023 have led to decreased consumption and hedging losses, but the market is expected to stabilize by 2026. CEO Peter Feld is implementing cost cuts of CHF 250 million, and if cocoa prices normalize, the company's valuation could potentially double. This article is sourced from an online content aggregator through publicly available sources and is displayed below for general informational purposes only. This article was originally published 3 months ago on Value Investors Club. 2.
cityfalcon.com
Brief India: NOCIL Ltd - Pricing Pressure Continues; Global Uncertainties Adding to the Woes and more
In this briefing: NOCIL Ltd - Pricing Pressure Continues; Global Uncertainties Adding to the Woes Affle 3i Ltd. - Mixed Performance; Strong Momentum to Continue Ambuja Cements Ltd - Beat Estimates On Lower Cost; Retain BUY City Union Bank Ltd. - Strong Quarter; Consistent RoA Delivery of Over 1.5% to Continue! NIFTY 50 Tactical Outlook Amidst Potential Passive Flows From Global Trackers 1. NOCIL Ltd - Pricing Pressure Continues; Global Uncertainties Adding to the Woes Subdued Performance: The company posted a modest 4% QoQ increase in volumes, while revenue declined 5% sequentially. Domestic sales remained resilient; however, export volumes were impacted by global macro headwinds and U.S. tariff-related challenges. Management expects steady growth in domestic volumes and gradual market share gains over the coming quarters. Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only.
cityfalcon.com
India stock benchmarks flat on consolidation after October rally
India’s equity benchmarks traded flat on Monday with analysts expecting consolidation after strong gains last month, while stock-specific reactions to quarterly earnings supported broader market activity. The Nifty 50 rose 0.1% to 25,747.45, while the BSE Sensexadded 0.02% to 83,956.75 as of 9:56 a.m. IST. Fourteen of the 16 major sectors logged gains. The small-caps and mid-caps rose 0.8% and 0.4%, respectively. The 50-stock index gained 4.5% in October - its best performance since March. On the day, state-owned lenders rose 1.5% to top sectoral gains while private banks and IT fell about 0.4% each. “While PSU banks climb on reports of a potential hike in foreign investment limits, investors are taking some chips off the table after the sustained rally,” said Vinod Nair, head of research at Geojit Investments. There will be further consolidation near current levels as investors await clarity on the global trade front, said two analysts. Among individual stocks, non-bank lender Shriram Finance rose 5.6% after posting a rise in quarterly profit.
cityfalcon.com

Advertisement|Remove ads.